tiprankstipranks
Spyre Therapeutics announces $180M private placement
PremiumThe FlySpyre Therapeutics announces $180M private placement
2M ago
Spyre Therapeutics price target raised to $50 from $44 at Guggenheim
PremiumThe Fly
Spyre Therapeutics price target raised to $50 from $44 at Guggenheim
2M ago
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
PremiumThe Fly
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
2M ago
Spyre Therapeutics Revamps Governance and Fiscal Year
PremiumCompany AnnouncementsSpyre Therapeutics Revamps Governance and Fiscal Year
3M ago
Spyre Therapeutics Announces Board Changes and Compensation Updates
PremiumCompany Announcements
Spyre Therapeutics Announces Board Changes and Compensation Updates
3M ago
Spyre Therapeutics Enhances Protection for Executives and Board
PremiumCompany Announcements
Spyre Therapeutics Enhances Protection for Executives and Board
3M ago
Spyre Therapeutics initiated with a Buy at BTIG
PremiumThe FlySpyre Therapeutics initiated with a Buy at BTIG
5M ago
Spyre Therapeutics price target raised to $27 from $23 at Stifel
PremiumThe Fly
Spyre Therapeutics price target raised to $27 from $23 at Stifel
5M ago
Spyre Therapeutics initiated with bullish view at Jefferies, here’s why
PremiumThe Fly
Spyre Therapeutics initiated with bullish view at Jefferies, here’s why
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100